Academic & industrial partnerships

& industrial

Our success depends on the partnerships we build.

To implement our scientific strategy, we have formed key academic partnerships with INRA (French National Institute for Agricultural Reasearch), ICAN (French Institute of Cardiometabolism and Nutrition), University of Reading (UK), University of Valencia (Spain), IHU Marseille (France).

Bioaster, Biomeostatis, BIOSE and LUINA BIO support LNC with the identification and production of our bacteria, preclinical development, and manufacturing in cGMP standard LNC candidate for clinical evaluation.

In the willingness of LNC to build our internal team, we will partner with academic partnerships.

Committed to become a major player in biotechnologies, the company plans to continue developing academic and/or industry partnerships with research teams working on microbiome-related topics.

Want to talk to our CEO ?

Leveraging partnership
for our success

Microbiome & us
Nov 5, 2019
LNC Therapeutics Announces Formation of its Scientific Advisory Board | Appoints international experts with...
> more
Oct 22, 2019
LNC Therapeutics chooses Luina Bio for the development and GMP manufacturing of its first live bio therapeutic product...
> more
Press / Media
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Sep 5, 2019
Capital increase supported by the Company’s historic shareholders, including Seventure Partners and a new family office...
> more
Jan 11, 2019
Comparison of the Gut Microbiota of Centenarians in Longevity Villages of South Korea with Those of Other Age Groups...
> more
Jan 2, 2019
Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders   Marialetizia...
> more
now on twitter
LNC Therapeutics

Researchers have found that people with a certain type of bacteria in their gut may be at a greater risk of develop…

LNC Therapeutics © 2019 - all rights reserved terms and conditions